FSCN1 and esophageal squamous cell carcinoma: Moreover, in esophageal squamous cell carcinoma, overexpression of the epidermal growth factor (EGF) increased specificity of protein 1 (Sp1) phosphorylation and activated the ERK1/2 pathway, thus enhancing FSCN1 expression [87] (Figure 1).